Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo

Osteoarthritis and Cartilage

Volumn 21, Issue 4, 2013, Pages 614-624

  Orth, P ^a   Cucchiarini, M ^a   Zurakowski, D ^b   Menger, M D ^a   Kohn, D M ^a   Madry, H ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cartilage repair; Osteochondral defect; PTH 1 34 ; PTH1R; Subchondral bone

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; BIOCHEMICAL COMPOSITION; BIOCHEMISTRY; BONE DEFECT; CARTILAGE CELL; CELL SURFACE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MICROSCOPY; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCHONDRAL BONE PLATE; SYNOVIUM; TISSUE REPAIR; TROCHLEAR NERVE;

ANIMALS; APOPTOSIS; BONE REGENERATION; CALCIUM; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN; DRUG EVALUATION, PRECLINICAL; FEMALE; FEMUR; INJECTIONS, INTRAMUSCULAR; OSTEOCYTES; PARATHYROID HORMONE; RABBITS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; SYNOVIAL MEMBRANE; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84874957698     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.01.008     Document Type: Article

References (50)

1. Orth P., Cucchiarini M., Kaul G., Ong M.F., Gräber S., Kohn D.M., et al. Temporal and spatial migration pattern of the subchondral bone plate in a rabbit osteochondral defect model. Osteoarthritis Cartilage 2012, 20(10):1161-1169.
2. Lajeunesse D. The role of bone in the treatment of osteoarthritis. Osteoarthritis Cartilage 2004, 12(Suppl A):S34-S38.
3. Madry H., van Dijk C.N., Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc 2010, 18(4):419-433.
4. Gomoll A.H., Farr J., Gillogly S.D., Kercher J., Minas T. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am 2010, 92(14):2470-2490.
5. Hangody L., Kish G., Karpati Z., Udvarhelyi I., Szigeti I., Bely M. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 1998, 21(7):751-756.
6. Ochs B.G., Muller-Horvat C., Albrecht D., Schewe B., Weise K., Aicher W.K., et al. Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee. Am J Sports Med 2011, 39(4):764-773.
7. Brittberg M. Autologous chondrocyte implantation-technique and long-term follow-up. Injury 2008, 39(Suppl 1):S40-S49.
8. Matricali G.A., Dereymaeker G.P., Luyten F.P. Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop Belg 2010, 76(5):669-674.
9. von Rechenberg B., Akens M.K., Nadler D., Bittmann P., Zlinszky K., Kutter A., et al. Osteochondral grafts. Osteoarthritis Cartilage 2003, 11(4):265-277.
10. Rhee Y., Allen M.R., Condon K., Lezcano V., Ronda A.C., Galli C., et al. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. J Bone Miner Res 2011, 26(5):1035-1046.
11. Weisser J., Riemer S., Schmidl M., Suva L.J., Poschl E., Brauer R., et al. Four distinct chondrocyte populations in the fetal bovine growth plate: highest expression levels of PTH/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1-34) and PTHrP (1-40). Exp Cell Res 2002, 279(1):1-13.
12. Bukata S.V. Systemic administration of pharmacological agents and bone repair: what can we expect. Injury 2011, 42(6):605-608.
13. Bukata S.V., Puzas J.E. Orthopedic uses of teriparatide. Curr Osteoporos Rep 2010, 8(1):28-33.
14. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344(19):1434-1441.
15. Kakar S., Einhorn T.A., Vora S., Miara L.J., Hon G., Wigner N.A., et al. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 2007, 22(12):1903-1912.
16. O'Loughlin P.F., Cunningham M.E., Bukata S.V., Tomin E., Poynton A.R., Doty S.B., et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976) 2009, 34(2):121-130.
17. Sampson E.R., Hilton M.J., Tian Y., Chen D., Schwarz E.M., Mooney R.A., et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 2011, 3(101):101ra93.
18. Chang J.K., Chang L.H., Hung S.H., Wu S.C., Lee H.Y., Lin Y.S., et al. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum 2009, 60(10):3049-3060.
19. Kudo S., Mizuta H., Takagi K., Hiraki Y. Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH/PTHrP signaling. Osteoarthritis Cartilage 2011, 19(7):886-894.
20. Goebel L., Orth P., Müller A., Zurakowski D., Bücker A., Cucchiarini M., et al. Experimental scoring systems for macroscopic articular cartilage repair correlate with the MOCART score assessed by a high-field MRI at 9.4 T - comparative evaluation of five macroscopic scoring systems in a large animal cartilage defect model. Osteoarthritis Cartilage 2012, 20(9):1046-1055.
21. Feldkamp L.A., Goldstein S.A., Parfitt A.M., Jesion G., Kleerekoper M. The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 1989, 4(1):3-11.
22. Weimer A., Madry H., Venkatesan J.K., Schmitt G., Frisch J., Wezel A., et al. Benefits of rAAV-mediated IGF-I overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis. Mol Med 2012, 18(1):346-358.
23. Kiernan J.A. Histological and Histochemical Methods - Theory and Practice 1999, Butterworth-Heinemann, Oxford.
24. Fortier L.A., Mohammed H.O., Lust G., Nixon A.J. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 2002, 84(2):276-288.
25. Madry H., Kaul G., Cucchiarini M., Stein U., Zurakowski D., Remberger K., et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005, 12(15):1171-1179.
26. Laverty S., Girard C.A., Williams J.M., Hunziker E.B., Pritzker K.P. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage 2010, 18(Suppl 3):S53-S65.
27. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994, 76(4):579-592.
28. Sellers R.S., Peluso D., Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1997, 79(10):1452-1463.
29. Orth P., Zurakowski D., Wincheringer D., Madry H. Reliability, reproducibility, and validation of five major histological scoring systems for experimental articular cartilage repair in the rabbit model. Tissue Eng Part C Methods 2012, 18(5):329-339.
30. Bland J.M., Altman D.G. Calculating correlation coefficients with repeated observations: part 2 - correlation between subjects. BMJ 1995, 310(6980):633.
31. Goldring M.B., Marcu K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 2009, 11(3):224.
32. Becher C., Szuwart T., Ronstedt P., Ostermeier S., Skwara A., Fuchs-Winkelmann S., et al. Decrease in the expression of the type 1 PTH/PTHrP receptor (PTH1R) on chondrocytes in animals with osteoarthritis. J Orthop Surg Res 2010, 5:28.
33. Dempster D.W., Cosman F., Kurland E.S., Zhou H., Nieves J., Woelfert L., et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001, 16(10):1846-1853.
34. Brouwers J.E., van Rietbergen B., Huiskes R., Ito K. Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT. Osteoporos Int 2009, 20(11):1823-1835.
35. Ellegaard M., Jorgensen N.R., Schwarz P. Parathyroid hormone and bone healing. Calcif Tissue Int 2010, 87(1):1-13.
36. Bellido M., Lugo L., Roman-Blas J.A., Castaneda S., Calvo E., Largo R., et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage 2011, 19(10):1228-1236.
37. Anraku Y., Mizuta H., Sei A., Kudo S., Nakamura E., Senba K., et al. Analyses of early events during chondrogenic repair in rat full-thickness articular cartilage defects. J Bone Miner Metab 2009, 27(3):272-286.
38. Novince C.M., Entezami P., Wilson C.G., Wang J., Oh S., Koh A.J., et al. Impact of proteoglycan-4 and parathyroid hormone on articular cartilage. J Orthop Res 2012 Aug 15, [Epub ahead of print].
39. Goldring M.B., Goldring S.R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 2010, 1192:230-237.
40. Henrotin Y., Pesesse L., Sanchez C. Subchondral bone in osteoarthritis physiopathology: state-of-the art and perspectives. Biomed Mater Eng 2009, 19(4-5):311-316.
41. Kudo S., Mizuta H., Otsuka Y., Takagi K., Hiraki Y. Inhibition of chondrogenesis by parathyroid hormone in vivo during repair of full-thickness defects of articular cartilage. J Bone Miner Res 2000, 15(2):253-260.
42. Feeley B.T., Doty S.B., Devcic Z., Warren R.F., Lane J.M. Deleterious effects of intermittent recombinant parathyroid hormone on cartilage formation in a rabbit microfracture model: a preliminary study. HSS J 2010, 6(1):79-84.
43. Lee J.H., Prakash K.V., Pengatteeri Y.H., Park S.E., Koh H.S., Han C.W. Chondrocyte apoptosis in the regenerated articular cartilage after allogenic chondrocyte transplantation in the rabbit knee. J Bone Joint Surg Br 2007, 89(7):977-983.
44. Jaiprakash A., Prasadam I., Feng J.Q., Liu Y., Crawford R., Xiao Y. Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis. Int J Biol Sci 2012, 8(3):406-417.
45. Lugo L., Villalvilla A., Gómez R., Bellido M., Sánchez-Pernaute O., Largo R., et al. Effects of PTH [1-34] on synoviopathy in an experimental model of osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage 2012, 20(12):1619-1630.
46. Coleman D.T., Bilezikian J.P. Parathyroid hormone stimulates formation of inositol phosphates in a membrane preparation of canine renal cortical tubular cells. J Bone Miner Res 1990, 5(3):299-306.
47. Wang Y., Nishida S., Boudignon B.M., Burghardt A., Elalieh H.Z., Hamilton M.M., et al. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 2007, 22(9):1329-1337.
48. Tsiridis E., Morgan E.F., Bancroft J.M., Song M., Kain M., Gerstenfeld L., et al. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. J Orthop Res 2007, 25(9):1193-1203.
49. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 1992, 7(1):65-72.
50. Hirano T., Burr D.B., Turner C.H., Sato M., Cain R.L., Hock J.M. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 1999, 14(4):536-545.